Inst Diagnosti Capital Reinvestment Ratio

Latest as of June 2023: 0.20x

Inst Diagnosti capital reinvestment ratio. Inst Diagnosti (INDISA) has a Capital Reinvestment Ratio of 0.20x as of June 2023, meaning it reinvests 0% of its operating cash flow (CL$8.87 Billion) in capital expenditures (CL$1.74 Billion). Check Inst Diagnosti investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.20x
Capex / Operating Cash Flow

Operating Cash Flow

CL$8.87 Billion
CLP

Capital Expenditures

CL$1.74 Billion
CLP

Data as of

Jun 2023
Most recent filing

Capital Reinvestment Ratio of Inst Diagnosti (2014–2021)

Capital reinvestment ratio of Inst Diagnosti from 2014 to 2021. This chart tracks Inst Diagnosti's Capital Reinvestment Ratio across 8 annual periods. Also explore Inst Diagnosti equity growth rate to track the company's year-over-year net asset growth rate.

Inst Diagnosti Capital Reinvestment Ratio by Year (2014–2021)

Inst Diagnosti capital reinvestment ratio by year from 2014 to 2021. For the full cash flow conversion analysis, see Inst Diagnosti (INDISA) cash conversion ratio.

Year Reinvestment Ratio Operating CF (CLP) Capital Expenditures YoY Change
2021 2.12x CL$14.83 Billion CL$31.45 Billion ▲ +146.2%
2020 0.86x CL$14.46 Billion CL$12.45 Billion ▲ +23.4%
2019 0.70x CL$10.66 Billion CL$7.44 Billion ▲ +118.0%
2018 0.32x CL$14.75 Billion CL$4.72 Billion ▼ -44.8%
2017 0.58x CL$14.89 Billion CL$8.63 Billion ▼ -31.0%
2016 0.84x CL$11.57 Billion CL$9.73 Billion ▲ +2.9%
2015 0.82x CL$15.05 Billion CL$12.30 Billion ▲ +84.0%
2014 0.44x CL$13.58 Billion CL$6.03 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow